Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 19, 2022Journal of Immunology ResearchOpen Access

Progression of Type 1 Diabetes: Circulating MicroRNA Expression Profiles Changes from Preclinical to Overt Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAritânia Sousa SantosUniversidade de São PauloLFLudmila Rodrigues Pinto FerreiraUniversidade Federal de Minas GeraisASAmanda Cabral da SilvaEmory University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Santos et al. (2022) studied this question.

synapsesocial.com/papers/69d8ef5c183921ebcaae4062https://doi.org/10.1155/2022/2734490
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Circulating microRNA (miRNA) Expression Profiling in Plasma of Patients with Gestational Diabetes Mellitus Reveals Upregulation of miRNA miR-330-3p2017 · 91 citations
  2. 2MicroRNA Expression in Alpha and Beta Cells of Human Pancreatic Islets2013 · 137 citations
  3. 3A miRNA181a/NFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabetes2018 · 63 citations
  4. 4The AHR Signaling Attenuates Autoimmune Responses During the Development of Type 1 Diabetes2020 · 36 citations
  5. 5miRNA-16-5p inhibits the apoptosis of high glucose-induced pancreatic β cells via targeting of CXCL10: potential biomarkers in type 1 diabetes mellitus2020 · 36 citations